For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Replimune Group Inc (NASDAQ: REPL) closed at $9.95 in the last session, down -2.26% from day before closing price of $10.18. In other words, the price has decreased by -$2.26 from its previous closing price. On the day, 1.18 million shares were traded. REPL stock price reached its highest trading level at $10.145 during the session, while it also had its lowest trading level at $9.84.
Ratios:
We take a closer look at REPL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.31 and its Current Ratio is at 6.31. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.27.
On October 27, 2025, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $12.
Wedbush Upgraded its Neutral to Outperform on October 20, 2025, while the target price for the stock was maintained at $18.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 09 ’25 when Dhingra Kapil sold 3,169 shares for $10.40 per share. The transaction valued at 32,958 led to the insider holds 0 shares of the business.
Kapil Dhingra bought 3,164 shares of REPL for $32,842 on Dec 09 ’25. On Dec 02 ’25, another insider, Patel Sushil, who serves as the Chief Executive Officer of the company, sold 10,000 shares for $11.13 each. As a result, the insider received 111,300 and left with 333,576 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REPL now has a Market Capitalization of 780511168 and an Enterprise Value of 533191168.
Stock Price History:
The Beta on a monthly basis for REPL is 0.73, which has changed by -0.13139933 over the last 52 weeks, in comparison to a change of 0.12838376 over the same period for the S&P500. Over the past 52 weeks, REPL has reached a high of $14.80, while it has fallen to a 52-week low of $2.68. The 50-Day Moving Average of the stock is 17.71%, while the 200-Day Moving Average is calculated to be 22.55%.
Shares Statistics:
According to the various share statistics, REPL traded on average about 5.02M shares per day over the past 3-months and 1941410 shares per day over the past 10 days. A total of 78.40M shares are outstanding, with a floating share count of 71.04M. Insiders hold about 9.44% of the company’s shares, while institutions hold 100.33% stake in the company. Shares short for REPL as of 1764288000 were 15273607 with a Short Ratio of 3.04, compared to 1761868800 on 16102363. Therefore, it implies a Short% of Shares Outstanding of 15273607 and a Short% of Float of 36.42.
Earnings Estimates
. The current rating of Replimune Group Inc (REPL) is the result of assessments by 5.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.84, with high estimates of -$0.69 and low estimates of -$0.95.
Analysts are recommending an EPS of between -$2.89 and -$3.73 for the fiscal current year, implying an average EPS of -$3.37. EPS for the following year is -$2.06, with 4.0 analysts recommending between -$1.04 and -$2.86.
